Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19José F. Varona, José Jimeno, José Barberán et al.|Life Science Alliance|2022Cited by 52
A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19Pedro Landete, José F. Varona, Olga Adriana Căliman-Sturdza et al.|Clinical Infectious Diseases|2024Cited by 16
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter CohortJorge Calderón‐Parra, Elena Múñez, Pablo Guisado‐Vasco et al.|Journal of Clinical Medicine|2023Cited by 11
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysisJosé F. Varona, Vicente Estrada, Pedro Landete et al.|Frontiers in Cellular and Infection Microbiology|2023Cited by 10
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalizationJosé F. Varona, Adolfo García‐Sastre, Pedro Landete et al.|medRxiv|2021Cited by 9